Clinical and Pathophysiological Description of Ocular Ischemic Syndrome

Sponsor
Glostrup University Hospital, Copenhagen (Other)
Overall Status
Completed
CT.gov ID
NCT00403195
Collaborator
Rigshospitalet, Denmark (Other), University Hospital, Gentofte, Copenhagen (Other)
13
1
26
0.5

Study Details

Study Description

Brief Summary

The purpose of this study is to characterize the disease Ocular Ischemic Syndrome.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The disease Ocular Ischemic Syndrome (OIS) is not a well described entity. It occurs after a long-standing period of extremely low blood supply to the retina caused by atherosclerosis of the carotid arteries. In this study we will analyze why OIS is developed in some patients and not developed in others. The patients with OIS will be thorough examined and will be compared with 1) a control group of healthy people and 2) with control group of patients with diabetic retinopathy. Furthermore the impact of vascular surgery on OIS will be analyzed.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    13 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Pathophysiological Analysis of Ocular Ischemic Syndrome and the Response to Vascular Surgery
    Study Start Date :
    Nov 1, 2006
    Actual Primary Completion Date :
    Jan 1, 2009
    Actual Study Completion Date :
    Jan 1, 2009

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:
      • Ocular ischemic syndrome
      Exclusion Criteria:
      • Any other active ocular disease

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Department of Ophthalmology, Glostrup Hospital, University of Copenhagen Glostrup Denmark 2600

      Sponsors and Collaborators

      • Glostrup University Hospital, Copenhagen
      • Rigshospitalet, Denmark
      • University Hospital, Gentofte, Copenhagen

      Investigators

      • Study Director: Michael Larsen, Professor,

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      Peter Kofoed, Principal investigator, Glostrup University Hospital, Copenhagen
      ClinicalTrials.gov Identifier:
      NCT00403195
      Other Study ID Numbers:
      • OIS
      First Posted:
      Nov 23, 2006
      Last Update Posted:
      Sep 10, 2012
      Last Verified:
      Sep 1, 2012
      Keywords provided by Peter Kofoed, Principal investigator, Glostrup University Hospital, Copenhagen
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Sep 10, 2012